BEVERLY, Mass., April 27, 2011 (GLOBE NEWSWIRE) -- Axcelis Technologies, Inc. (Nasdaq:ACLS) today announced financial results for the first quarter ended March 31, 2011. Revenue for the first quarter was $93.2 million, compared with $93.4 million in Q4, and $48.5 million for the same period a year ago. Net income for the quarter was $1.8 million, or $0.02 per diluted share. Prior quarter net income was $4.3 million or $0.04 per diluted share, of which $2.1 million or $0.02 per diluted share was attributable to a one-time tax benefit. In the prior year period, the company reported a net loss of $11.1 million, or $0.11 cents per share. Cash and cash equivalents, including restricted cash, were $44.9 million at March 31, 2011.
Commenting on the Company's performance, Chairman and CEO Mary Puma said, "Axcelis is off to a solid start in 2011. The momentum we built in 2010 with our Optima and Integra product lines is accelerating as customers continue to recognize the productivity and technological advantages our systems provide." She continued, "As expected, we gained market share in implant in 2010, particularly in high current and in high energy. Over the next year, we plan to continue to introduce highly differentiated technology, further expanding our customer base and gaining additional market share."
First Quarter 2011 Conference Call
The Company will host a conference call today at 5:00 pm ET to discuss results for the first quarter of 2011. The call will be available to interested listeners via an audio webcast that can be accessed through Axcelis' home page at www.axcelis.com, or by dialing 1-888-713-4205 (1-617-213-4862 outside North America). Participants calling into the conference call will be requested to provide the company name, Axcelis Technologies and pass code: 49696794. Webcast replays will be available from 8 pm ET on April 27, 2011 until 11:59 pm on June 26, 2011.
Safe Harbor Statement
This document contains forward-looking statements under the SEC safe harbor provisions. These statements, which include our guidance for future financial performance, are based on management's current expectations and should be viewed with caution. They are subject to various risks and uncertainties, many of which are outside the control of the Company, including the timing of orders and shipments, the conversion of orders to revenue in any particular quarter, or at all, our ability to implement successfully our profit plans, the continuing demand for semiconductor equipment, relative market growth, continuity of business relationships with and purchases by major customers, competitive pressure on sales and pricing, increases in material and other production costs that cannot be recouped in product pricing and global economic, political and financial conditions. These risks and other risk factors relating to Axcelis are described more fully in the most recent Form 10-K filed by Axcelis and in other documents filed from time to time with the Securities and Exchange Commission.
About Axcelis
Axcelis Technologies, Inc. (Nasdaq:ACLS) headquartered in Beverly, Massachusetts, provides innovative, high-productivity solutions for the semiconductor industry. Axcelis is dedicated to developing enabling process applications through the design, manufacture and complete life cycle support of ion implantation and cleaning systems. The company's Internet address is: www.axcelis.com.
| Axcelis Technologies, Inc. | ||
| Consolidated Statements of Operations | ||
| In thousands, except per share amounts | ||
| (Unaudited) | ||
| Three months ended | ||
| March 31, | ||
| 2011 | 2010 | |
| Revenue | ||
| Product | $ 86,603 | $ 40,278 |
| Service | 6,567 | 8,222 |
| 93,170 | 48,500 | |
| Cost of revenue | ||
| Product | 56,873 | 30,320 |
| Service | 5,216 | 5,173 |
| 62,089 | 35,493 | |
| Gross profit | 31,081 | 13,007 |
| Operating expenses | ||
| Research and development | 11,818 | 9,133 |
| Sales and marketing | 7,819 | 6,604 |
| General and administrative | 9,055 | 7,700 |
| 28,692 | 23,437 | |
| Income (loss) from operations | 2,389 | (10,430) |
| Other income (expense) | ||
| Interest income | 6 | 29 |
| Other, net | (450) | (407) |
| (444) | (378) | |
| Income (loss) before income taxes | 1,945 | (10,808) |
| Income taxes | 133 | 293 |
| Net Income (loss) | $ 1,812 | $ (11,101) |
| Net income (loss) per share | $ 0.02 | $ (0.11) |
| Basic | $ 0.02 | $ (0.11) |
| Diluted | ||
| Shares used in computing net income (loss) per share | 105,936 | 104,116 |
| Basic | 110,791 | 104,116 |
| Axcelis Technologies, Inc. | ||
| Consolidated Balance Sheets | ||
| In thousands | ||
| (Unaudited) | ||
| March 31, | December 31, | |
| 2011 | 2010 | |
| ASSETS | ||
| Current assets | ||
| Cash and cash equivalents | $ 44,782 | $ 45,743 |
| Accounts receivable, net | 49,948 | 57,888 |
| Inventories, net | 123,356 | 109,653 |
| Prepaid expenses and other current assets | 11,026 | 15,346 |
| Total current assets | 229,112 | 228,630 |
| Property, plant and equipment, net | 38,315 | 38,594 |
| Long-term restricted cash | 113 | 107 |
| Other assets | 18,770 | 13,541 |
| $ 286,310 | $ 280,872 | |
| LIABILITIES AND STOCKHOLDERS' EQUITY | ||
| Current liabilities | ||
| Accounts payable | $ 38,064 | $ 36,709 |
| Accrued compensation | 12,877 | 10,597 |
| Warranty | 3,060 | 2,556 |
| Deferred revenue | 10,880 | 13,859 |
| Other current liabilities | 3,855 | 4,408 |
| Total current liabilities | 68,736 | 68,129 |
| Long-term deferred revenue | 2,417 | 2,417 |
| Other long-term liabilities | 5,090 | 4,759 |
| Stockholders' equity | ||
| Preferred stock | -- | -- |
| Common stock | 106 | 106 |
| Additional paid-in capital | 495,330 | 493,967 |
| Treasury stock | (1,218) | (1,218) |
| Accumulated deficit | (291,708) | (293,520) |
| Accumulated other comprehensive income | 7,557 | 6,232 |
| 210,067 | 205,567 | |
| $ 286,310 | $ 280,872 | |
| Axcelis Technologies, Inc. | ||
| Consolidated Statements of Cash Flow | ||
| In thousands | ||
| (Unaudited) | ||
| Three months ended | ||
| March 31, | ||
| 2011 | 2010 | |
| Cash flows from operating activities | ||
| Net loss | $ 1,812 | $ (11,101) |
| Adjustments to reconcile net loss to net cash used for operating activities | ||
| Depreciation and amortization | 1,882 | 1,937 |
| Deferred taxes | 33 | 167 |
| Stock-based compensation expense | 1,222 | 817 |
| Provision for excess inventory | 246 | 758 |
| Changes in operating assets & liabilities: | ||
| Accounts receivable | 8,245 | (15,425) |
| Inventories | (13,350) | 8,252 |
| Prepaid expenses and other current assets | 4,404 | (362) |
| Accounts payable & other current liabilities | 3,168 | 4,922 |
| Deferred revenue | (2,996) | 526 |
| Income taxes | 3 | (408) |
| Other assets and liabilities | (5,875) | 54 |
| Net cash used for operating activities | (1,206) | (9,863) |
| Cash flows from investing activities | ||
| Expenditures for property, plant, and equipment | (610) | (263) |
| Decrease (increase) in restricted cash | (6) | 319 |
| Net cash provided by (used for) investing activities | (616) | 56 |
| Cash flows from financing activities | ||
| Financing fees and other expenses | -- | (431) |
| Proceeds from exercise of stock options | 197 | 32 |
| Proceeds from Employee Stock Purchase Plan | 239 | 169 |
| Net cash provided by (used for) financing activities | 436 | (230) |
| Effect of exchange rate changes on cash | 425 | (182) |
| Net decrease in cash and cash equivalents | (961) | (10,219) |
| Cash and cash equivalents at beginning of period | 45,743 | 45,020 |
| Cash and cash equivalents at end of period | $ 44,782 | $ 34,801 |